文献速递脑血管病外科

小体积(≤5 mL)未破裂脑动静脉畸形的首选与重复伽玛刀放射外科治疗:249例连续患者队列

Upfront and Repeated Gamma-Knife Radiosurgery for Small (≤5 mL) Unruptured Brain Arteriovenous Malformation: A Cohort of 249 Consecutive Patients.
PubMed 文献 · World Neurosurg · 2021-11-27

该回顾性研究纳入1992至2014年249例符合ARUBA纳入标准、体积≤5 mL的未破裂脑动静脉畸形患者,接受首选及重复伽玛刀放射外科治疗并随访至少3年。总体畸形血管团闭塞率为77.1%,治疗后出血年发生率为1.03%,永久性症状性放射诱导改变率为2%,作者认为低毒性率和高闭塞率支持首选及重复伽玛刀治疗。

要点

  • 249例≤5 mL未破裂脑动静脉畸形接受伽玛刀,总体闭塞率77.1%。
  • 治疗后出血8例(3.2%),年出血率1.03%。
  • 永久性症状性放射诱导改变率2%。

核心结论

  • 极低的毒性率和高的闭塞率支持对未破裂小体积(≤5 mL)脑动静脉畸形行首选及重复伽玛刀放射外科治疗。

研究设计与样本

  • 回顾性研究,评估1992至2014年符合ARUBA纳入标准、体积≤5 mL的未破裂初治脑动静脉畸形接受伽玛刀放射外科治疗且随访至少3年的结局。
  • 共249例患者符合纳入标准,中位年龄36岁(范围18-78岁)。

主要发现

  • 畸形血管团中位治疗体积1.3 mL(范围0.4-5 mL),63%位于功能区。
  • 放射外科基于脑动静脉畸形评分1-1.8分占76%,Spetzler-Martin分级II-III级占73%,Virginia放射外科脑动静脉畸形量表≤1分占75%。
  • 最多3次伽玛刀治疗后总体闭塞率为77.1%。
  • 边缘中位剂量24 Gy(范围15-25 Gy),中位随访45个月(范围36-205个月)。
  • 治疗后出血8例(3.2%),对应治疗后出血年发生率为1.03%;永久性症状性放射诱导改变率为2%(4例癫痫发作增加,1例神经功能缺损)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: According to A Randomized Trial of Unruptured Brain Arteriovenous Malformations (ARUBA), conservative treatment seems to be superior to any intervention for unruptured brain arteriovenous malformations (AVMs). This study aims to evaluate safety and efficacy of upfront and repeated Gamma-Knife Radiosurgery (GKRS) in patients harboring small AVMs fulfilling the inclusion criteria of ARUBA. METHODS: A retrospective study was conducted to evaluate outcomes of unruptured naive brain AVM with a volume ⩽ 5 mL eligible to ARUBA treated by GKRS with at least 3 years of follow-up. RESULTS: From 1992 to 2014, 249 patients fulfilled the inclusion criteria of this study. The median age was 36 years (range: 18-78 years). The median treated volume of the nidus was 1.3 mL (range: 0.4-5 mL) and 63% of the AVM were in eloquent areas. Radiosurgery-based AVM score was 1-1.8 (76%), the Spetzler-Martin grade was II-III (73%), and the Virginia Radiosurgery AVM scale was ≤1 point (75%). The overall AVM obliteration rate was 77.1% after up to 3 GKRS sessions. The median dose at the margin was 24 Gy (15-25 Gy) and the median follow-up was 45 months (range: 36-205 months). Eight patients (3.2%) experienced hemorrhage after GKRS, corresponding to a post-GKRS hemorrhage annual rate of 1.03%. Permanent symptomatic radio-induced changes rate was 2% (4 increased seizures, 1 neurologic deficit). CONCLUSIONS: The very low toxicity rate and the high occlusion rate suggest in favor of upfront and repeated GKRS for unruptured small AVMs (⩽5 mL).

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Hak JF, Borius PY, Spatola G, et al. Upfront and Repeated Gamma-Knife Radiosurgery for Small (≤5 mL) Unruptured Brain Arteriovenous Malformation: A Cohort of 249 Consecutive Patients. World Neurosurg. 2021. PMID: 34844005. doi:10.1016/j.wneu.2021.11.091

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。